Observational Study
Copyright ©The Author(s) 2024.
World J Clin Oncol. Aug 24, 2024; 15(8): 1048-1060
Published online Aug 24, 2024. doi: 10.5306/wjco.v15.i8.1048
Figure 1
Figure 1 Flow diagram outlining the cases and controls for comparing the prevalence of malignant neoplasm in celiac disease and non-celiac disease patients. CeD: Celiac disease.
Figure 2
Figure 2 Flow diagram outlining the cases and controls for comparing the hospital outcomes of celiac disease with malignant neoplasm vs non-celiac disease with malignant neoplasm. CeD: Celiac disease; NIS: National Inpatient Sample; MN: Malignant neoplasm.
Figure 3
Figure 3 Trend of in-hospital mortality and the mean length of stay of hospitalized of celiac disease patients with malignant neoplasm vs matched non-celiac disease with malignant neoplasm (matched by age-, sex-, race-, and corresponding malignant neoplasm), National Inpatient Sample 2000-2019. A: Trend of in-hospital mortality of celiac disease (CeD) patients with malignant neoplasm (MN) vs matched non-CeD with MN; B: Trend of the mean length of stay of hospitalized CeD patients with MN vs matched non-CeD with MN. CeD: Celiac disease.